Ambrose Kristen sold VRTX
February 26, 2026 · Form 4 insider transaction
Ambrose Kristen sold 357 shares of Vertex Pharmaceuticals Incorporated at $483.36 per share, a transaction worth $172.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
357
Price
$483.36
Total value
$172.6K
InsiderAmbrose Kristen
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2026
Filing dateMarch 2, 2026
Shares owned after6,624
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2025.